Akari Therapeutics Appoints Vatnak Vat-Ho Chief Business Officer
Vat-Ho will lead strategy, partnering, licensing and investor engagement.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results.
Akari Therapeutics appoints Vatnak Vat — Ho chief business officer
Akari Therapeutics named Vatnak Vat-Ho chief business officer to lead corporate strategy, partnering, licensing, investor engagement. Vat-Ho brings 20+ years in oncology business development, biopharma strategy, equity research, healthcare investing; worked on deals totaling $25 billion. Most recently served as chief b
Akari Therapeutics appoints Vatnak Vat-Ho as chief business officer
The company said Vat-Ho brings more than 20 years of oncology, biopharma and capital-markets experience, including experience in transactions totaling more than $25 billion in aggregate value.
Akari Therapeutics appoints Vatnak Vat-Ho chief business officer
The company said Vatnak Vat-Ho will lead business development and partnering.